Category: Joint ventures/collaborations
-
Forensic Genomics Company Spun-Off From Illumina
A new company is being established to provide genomics analysis systems for law enforcement, spun-off from a leading maker of genomics systems.
-
Smartphones Capturing Multiple Sclerosis Data
A large-scale research study of physical challenges and symptoms in people with multiple sclerosis in the U.S. is capturing its data with smartphones rather than by visiting clinics.
-
AstraZeneca, Biotech Partner on Messenger RNA Therapies
Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments.
-
Alliance to Develop Rare Cancer Preclinical Models
A coalition of a patient advocacy organization, research institute, and cancer research company are implanting mice with human tumors to help study a rare form of cancer.
-
Parkinson’s Protein Experiment in Space Station Cargo
An experiment to grow a crystallized form of protein associated with Parkinson’s disease is among the cargo that lifted off today from NASA’s Kennedy Space Center.
-
Trial to Test Inhaled Insulin, App for Diabetes Mgmt
A clinical trial is planned to test the benefits of managing type 2 diabetes with an inhaled formulation of insulin and a smartphone app.
-
Study Underway of Depression, Bipolar Disorder Genetics
A large-scale study by two companies and a think tank started enrolling participants to learn more about the role of genetics in major depressive and bipolar disorders.
-
University, Company Employ AI for Anti-Aging Drugs
The medical analytics company Insilico Medicine is partnering with a university in Denmark to apply artificial intelligence to find new treatments for diseases associated with early aging.
-
Exosuit Shown to Improve Walking for Stroke Patients
A robotic device built and worn like clothing helps improve lower-limb walking performance for a group of people partially paralyzed with stroke.
-
Takeda, Biosurfaces Partner on Nanofiber Devices
Takeda Pharmaceutical Company is joining with a developer of medical devices from nanoscale bioactive fibers to design new devices for gastrointestinal, or GI, disorders.